WebThe latest price target for Prometheus Biosciences ( NASDAQ: RXDX) was reported by Guggenheim on Monday, March 6, 2024. The analyst firm set a price target for 225.00 expecting RXDX to rise... WebAnalysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Prometheus Biosciences (RXDX) and Travere Therapeutics (TVTX) March 28, 2024TipRanks. …
News Releases Prometheus Biosciences
WebDec 9, 2024 · Prometheus Biosciences ( NASDAQ: RXDX) has priced an underwritten offering of 4,545,455 shares of its common stock at a price to the public of $110/share, for an expected gross proceeds of... WebDec 8, 2024 · Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock. SAN DIEGO, Dec. 08, 2024 (GLOBE NEWSWIRE) -- … イング 服 年齢層
Prometheus Biosciences, Inc. Announces Pricing of Public …
WebThe 11 analysts offering 12-month price forecasts for Prometheus Biosciences Inc have a median target of 155.00, with a high estimate of 225.00 and a low estimate of 138.00. The median estimate ... WebMar 11, 2024 · The San Diego, CA-based company now plans to raise $167 million by offering 9 million shares at a price ... RXDX. Prometheus Biosciences raises deal size by 33% ahead of $167 million IPO. WebDec 7, 2024 · SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision … padaria da cancela telefone